{"id":9077,"date":"2018-08-13T00:00:00","date_gmt":"2018-08-13T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2018\/08\/13\/fda-warns-against-long-term-azithromycin-use-for-some\/"},"modified":"2018-08-14T16:06:01","modified_gmt":"2018-08-14T16:06:01","slug":"fda-warns-against-long-term-azithromycin-use-for-some","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2018\/08\/13\/fda-warns-against-long-term-azithromycin-use-for-some\/","title":{"rendered":"FDA Warns Against Long-Term Azithromycin Use for Some"},"content":{"rendered":"<h3>Warning for blood cancer patients who have undergone donor stem cell transplant<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>MONDAY, Aug. 13, 2018 (HealthDay News) &#8212; The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant not to take azithromycin, as long-term use of the antibiotic has been associated with increased risk of cancer relapse.<\/p>\n<p>In a clinical trial, azithromycin was being used to prevent bronchiolitis obliterans syndrome in patients with cancers of the blood or lymph nodes who underwent a donor stem cell transplant. However, long-term use of the antibiotic was tied to cancer relapse and death.<\/p>\n<p>&#8220;Health care professionals should not prescribe long-term azithromycin for prophylaxis of bronchiolitis obliterans syndrome to patients who undergo donor stem cell transplants because of the increased potential for cancer relapse and death,&#8221; the agency said in a statement.<\/p>\n<p>Health care professionals and patients are encouraged to report adverse events or side effects related to the use of azithromycin to the FDA&#8217;s MedWatch Safety Information and Adverse Event Reporting Program.<\/p>\n<p><a href=\"https:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm615738.htm\" target=\"_new\">More Information<\/a><\/p>\n<p><a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/medwatch\/index.cfm?action=reporting.home\" target=\"_new\">MedWatch Reporting<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2018 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\">HealthDay<\/a>. All rights reserved.<\/i>   <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Warning for blood cancer patients who have undergone donor stem cell transplant<\/p>\n","protected":false},"author":6,"featured_media":9112,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-9077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/9077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=9077"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/9077\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/9112"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=9077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=9077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=9077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}